A blockbuster international deal announced Wednesday, in which New Jersey-based health products giant Johnson & Johnson has agreed to buy medical device maker Synthes for $21.3 billion, could have a ...

EAST GOSHEN – U.S. regulators warned Swiss medical device maker Synthes Inc. about violations at its Brandywine plant on Goshen Parkway and said the company may have to pay a fine if it fails to fix ...

NEW BRUNSWICK — Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion, adding devices to treat bone fractures and trauma in the biggest purchase in the company's 125-year history. Synthes ...

Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

ZURICH/NEW YORK (Reuters) - Johnson & Johnson will buy Swiss medical devices maker Synthes Inc for $21.67 billion, placing a big bet on growing its orthopedics business with one of the largest deals ...

TRENTON, N.J. — Healthcare giant Johnson & Johnson said that it will complete its $19.7 billion purchase of Synthes today — a deal J&J hopes will give it a dominant position in the growing orthopedic ...

The sentencing of three of the four ex-directors of medical device manufacturer Synthes to terms ranging from five to nine months over the unauthorized use of bone cement in spinal surgery clinical ...

Fourth Synthes Executive Pleads Guilty to Illegal Clinical Trials A fourth executive from West Chester, Pa.-based Synthes pleaded guilty to charges originating with illegal clinical trials the company ...

March 6 (Reuters) - U.S. regulators warned Swiss medical device maker Synthes Inc about violations at its plant in Pennsylvania, and said the company may have to pay a fine if it fails to fix the ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...